Heffron Thomas G, Pillen Todd, Smallwood Gregory, Henry Stuart, Sekar Sundari, Casper Katherine, Solis David, Tang Wenhao, Fasola Carlos, Romero Rene
Children's Healthcare of Atlanta, Atlanta, GA 30322, USA.
Pediatr Transplant. 2010 Sep 1;14(6):722-9. doi: 10.1111/j.1399-3046.2009.01259.x. Epub 2010 Mar 22.
PVT or PVS and HVOO are known causes of graft and patient loss after pediatric liver transplantation. Increased incidences of these complications have been reported in partial livers including DDSLT or LDLT. From 1997 to 2008, 241 consecutive pediatric patients received 271 hepatic grafts at a single center. Median follow-up is 1856 days. Surgical technique, demographics, lab values, and radiologic imaging procedures were obtained utilizing OTTR to evaluate the relationship of portal and hepatic complications with risk factors, patient and graft survival. Grafts were composed of 115/271 (42.4%) partial livers of which 90 (33.2%) were DDSLT and 25 (9.2%) LDLT. Of 271 patients, 156 (57.6%) received whole-sized grafts. There were six PVC in five patients with one patient requiring retransplantation (0.34%) and no patient deaths. Utilizing all three hepatic vein orifices on the recipient hepatic vena cava and the donor hepatic vein cut short enables a wide hepatic outflow tract unlikely to twist. None of the 241 patients developed early or late complications of the hepatic vein. None of the last 128 consecutive patients who received 144 grafts over seven and a half yr have developed either early or late complications of the hepatic or portal vein. Partial-graft actuarial survival was similar to whole-graft survival (87.2% vs. 85.3% at one yr; 76.6% vs. 80.2 at three yr; p = 0.488). Likewise, patient survival was similar between partial grafts and whole grafts (93.8% vs. 93.1% at one yr; 89.8% vs. 87.2% at three yr; p = 0.688) with median follow-up of 1822 (+/-1334) days. Patients receiving partial livers were significantly younger and smaller than patients receiving whole livers (p < 0.001). Portal and hepatic venous complications may have negative effects on patient or graft survival after pediatric liver transplantation. In our series, there was one graft and no patient loss related to portal or hepatic venous complications after pediatric liver transplantation over 12 yr.
门静脉血栓形成(PVT)或门静脉狭窄(PVS)以及肝静脉流出道梗阻(HVOO)是小儿肝移植后移植物和患者死亡的已知原因。在包括多米诺肝段移植(DDSLT)或活体肝移植(LDLT)在内的部分肝移植中,这些并发症的发生率有所增加。1997年至2008年,在单一中心,241例连续的小儿患者接受了271例肝移植。中位随访时间为1856天。利用器官移植跟踪登记系统(OTTR)获取手术技术、人口统计学资料、实验室检查值和影像学检查结果,以评估门静脉和肝并发症与危险因素、患者及移植物存活之间的关系。移植物包括115/271例(42.4%)部分肝,其中90例(33.2%)为DDSLT,25例(9.2%)为LDLT。271例患者中,156例(57.6%)接受了全尺寸移植物。5例患者发生了6例门静脉狭窄,1例患者需要再次移植(0.34%),无患者死亡。在受体肝静脉上利用所有三个肝静脉开口且将供体肝静脉剪短,可形成宽阔的肝流出道,不太可能发生扭曲。241例患者均未发生肝静脉的早期或晚期并发症。在过去连续7年半中接受144例移植物的最后128例患者,均未发生肝静脉或门静脉的早期或晚期并发症。部分移植物的精算生存率与全移植物生存率相似(1年时分别为87.2%和85.3%;3年时分别为76.6%和80.2%;p = 0.488)。同样,部分移植物和全移植物的患者生存率相似(1年时分别为93.8%和93.1%;3年时分别为89.8%和87.2%;p = 0.688),中位随访时间为1822(±1334)天。接受部分肝移植的患者比接受全肝移植的患者明显更年轻、体型更小(p < 0.001)。门静脉和肝静脉并发症可能对小儿肝移植后的患者或移植物存活产生负面影响。在我们的系列研究中,在12年的小儿肝移植中,没有因门静脉或肝静脉并发症导致移植物丢失,也没有患者死亡。